Prediction of<sup>177</sup>Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN StudyMagdalena Mileva, Ioannis Karfis, Simona Picchia et al.|Journal of Nuclear Medicine|2023Cited by 52
Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAlessandro Audisio, Francesco Fiorica, Chiara Gallio et al.|JAMA Oncology|2025Cited by 24
Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelinesGiacomo Bregni, Francesco Sclafani, Tuğba Akın Telli et al.|Cancer Treatment Reviews|2019Cited by 19
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancerGiacomo Bregni, Francesco Sclafani, Caroline Vandeputte et al.|Acta Oncologica|2021Cited by 11